About National Institute of Cardiovascular Diseases
Clinical Trials at National Institute of Cardiovascular Diseases
During the past decade, National Institute of Cardiovascular Diseases conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at National Institute of Cardiovascular Diseases
According to Clinical.Site data, the most researched conditions in "National Institute of Cardiovascular Diseases" are
"Acute Coronary Syndrome" (3 trials), "Analgesia" (1 trials), "Coronary Artery Bypass Grafting Surgery" (1 trials), "Coronary Artery Disease" (1 trials) and "Heart Failure, Systolic" (1 trials). Many other conditions were trialed in "National Institute of Cardiovascular Diseases" in a lesser frequency.
Clinical Trials Intervention Types at National Institute of Cardiovascular Diseases
Most popular intervention types in "National Institute of Cardiovascular Diseases" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Adenosine" (1 trials), "Adrenaline" (1 trials), "Ketorolac Injection" (1 trials), "Paracetamol" (1 trials) and "Rivaroxaban" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Institute of Cardiovascular Diseases
The vast majority of trials in "National Institute of Cardiovascular Diseases" are
5 trials for "All" genders.
Clinical Trials Status at National Institute of Cardiovascular Diseases
Currently, there are NaN active trials in "National Institute of Cardiovascular Diseases".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in National Institute of Cardiovascular Diseases,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Institute of Cardiovascular Diseases, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 1 trials that are defined as “Not Applicable".